AI-generated summary
This review discusses evidence for direct and indirect neuroprotective effects of photobiomodulation in Parkinson's disease, comparing intracranial delivery with extracranial or remote application. The authors report that animal models and early human observations have been positive, most consistently for non-motor symptoms, but the mechanisms are not clear. They propose that combining intracranial and extracranial devices may provide the best option.
- Who or what was studied
- People with Parkinson's disease and animal models of Parkinson's disease
- Limits stated in the abstract
- The abstract describes a narrative review and states that the precise mechanisms behind the improvements are not clear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.